Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cruzar Medsystems
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cruzar Medsystems

Cruzar Medsystems

Closed

Cruzar Medsystems Inc.: Massachusetts-based medical device manufacturer, specializing in peripheral vasculature access.

HQ
Braintree, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded in 2013 and based in Braintree, Massachusetts, Cruzar Medsystems Inc. is a medical device manufacturer specializing in products designed for accessing peripheral vasculature. The company's core mission is to innovate and enhance medical procedures related to vascular access, aiming to improve patient outcomes and streamline healthcare practices. Their market focus is primarily on the healthcare industry, targeting medical professionals and institutions that require advanced vascular access solutions.

Notable affiliated individuals and investors are not publicly detailed, but the company has made significant strides in the medical device sector since its inception. Key achievements include the development and commercialization of specialized devices that have potentially improved procedural efficiency and patient care within their niche. Cruzar Medsystems Inc. continues to impact the healthcare industry by providing essential tools that support critical medical interventions.

Cruzar Medsystems - Similar Companies

Cross Vascular logo

Cross Vascular

Traverse Vascular logo

Traverse Vascular

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Access Vascular logo

Access Vascular

Recros Medica logo

Recros Medica

Clarimedix logo

Clarimedix

Versago Vascular Access logo

Versago Vascular Access

Mercator Medsystems logo

Mercator Medsystems

mercatormed.com

Micro Medical Solutions logo

Micro Medical Solutions

Hemova Medical logo

Hemova Medical

Phraxis logo

Phraxis

phraxis.com

Atraverse Medical logo

Atraverse Medical

Bioconnect Systems logo

Bioconnect Systems

AccuVein logo

AccuVein

accuvein.com

Concept Medical logo

Concept Medical

conceptmedical.com

Cruzar Medsystems - Quick Facts

Who are Cruzar Medsystems' competitors?

Companies similar to Cruzar Medsystems include Cross Vascular, Traverse Vascular, Bluegrass Vascular Technologies and Access Vascular.

When was Cruzar Medsystems founded?

Cruzar Medsystems was founded in 2013.

Where is Cruzar Medsystems' headquarters located?

Cruzar Medsystems' headquarters is located in Braintree, MA, US.

When was Cruzar Medsystems' last funding round?

Cruzar Medsystems' most recent funding round was for $2.3M (USD) in June 2017.

How much has Cruzar Medsystems raised to-date?

As of Jun 1, 2017, Cruzar Medsystems has raised a total of $8.8M (USD).

Cruzar Medsystems - Classification

NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified